Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001731122-25-000973
Filing Date
2025-07-14
Accepted
2025-07-14 16:30:58
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 e6699_s-3.htm S-3 174736
2 EXHIBIT 5.1 e6699_ex5-1.htm EX-5.1 8505
3 EXHIBIT 23.1 e6699_ex23-1.htm EX-23.1 3274
4 EXHIBIT 107 e6699_ex107.htm EX-FILING FEES 28749
5 GRAPHIC ex5-1_001.jpg GRAPHIC 2889
6 GRAPHIC image_001.gif GRAPHIC 2822
7 GRAPHIC image_001.jpg GRAPHIC 2307
  Complete submission text file 0001731122-25-000973.txt   227829
Mailing Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111
Business Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111 844-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 980608404 | Fiscal Year End: 0930
Type: S-3 | Act: 33 | File No.: 333-288661 | Film No.: 251122048
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)